Company Hires Eight New Scientists to Deepen Understanding of Krill
Aker BioMarine is significantly expanding its research commitment in the krill marketplace. As part of this effort, eight new scientists will join the company this month to broaden the knowledge and understanding of krill, with a particular focus on clinical outcomes and new product applications.
The new team is comprised of several individuals with expertise in R&D, Regulatory Affairs and Product Development. They include Finn Myhren, PhD, R&D; Wenche Rasch, PhD, R&D; Petter-Arnt Hals, PhD, R&D; Stefan Hupfeld, PhD, R&D; Tore Duvold, PhD, R&D; Trygve Bergeland, PhD, R&D; Hanne Loken, PhD, Regulatory Affairs; and Tove Flem Jacobsen, MSc, R&D.
“Aker BioMarine has always been committed to investing in krill research – this is the next logical step in that direction,” said Tim de Haas, Vice President of Business Development. “This is a substantial investment that will give us the internal resources we need to follow through on some of the development ideas we have and deliver what the market is asking for.”
An improved consumer experience (i.e., smaller capsules, no fishy burps, better tolerability, etc.) for nutrients essential to better health has fueled krill’s solid double-digit growth in each of the past few years, making it the fastest growing segment in the omega-3 category. This is creating new opportunities for greater product diversification and application.
Matts Johansen, Chief Operating Officer, Aker BioMarine, commented: “From research and development to clinical studies to regulatory and market execution, this is a seasoned group of scientists that have worked many years in successful professional environments. They are just what we need to follow through on our big plans for Superba(TM) Krill.”
For more information, please contact:
Becky Wright, +1-206-855-6736 x 210
Roar Hernes, +47-241-30123
Chris McReynolds, +1-206-660-6756
Lalen Dogan, +61-3-9999-1112
About SuperbaTM Krill
Superba(TM) Krill is a pure, natural source of the health-promoting EPA and DHA omega-3 fatty acids and the naturally occurring antioxidant astaxanthin. Superba(TM) Krill is unique in that the omega-3 fatty acids are provided in phospholipid form. In vitro, in vivo and human clinical research has demonstrated the safety and efficacy of Superba(TM) Krill.
About Aker BioMarine
Aker BioMarine is an integrated biotechnology company dedicated to the sustainable harvesting of krill and development of krill-derived biotech products. The company supplies biomarine ingredients through an optimized value chain. Aker BioMarine’s Superba(TM) Krill products are provided with 100% traceability from sea to shelf. Only Aker’s krill fishery has been awarded Marine Stewardship Council (MSC) certification.